Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Paralysis
ADR ID BADD_A03295
ADR Hierarchy
17      Nervous system disorders
17.01      Movement disorders (incl parkinsonism)
17.01.04      Paralysis and paresis (excl cranial nerve)
17.01.04.004      Paralysis
Description A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45) [MeSH]
MedDRA Code 10033799
MeSH ID D010243
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Flaccid paralysis | Neuroparalysis | Other paralytic syndromes | Other paralytic syndromes, other | Other specified paralytic syndrome | Other specified paralytic syndromes | Palsy | Paralysed | Paralysis | Paralysis central progressive | Paralysis flaccid | Paralysis muscle general skeletal | Paralysis muscle local skeletal | Paralysis NOS | Paralysis periodic | Paralysis skeletal muscle | Paralysis spastic | Paralysis spastic (excl congenital) | Paralysis voluntary muscle | Paralysis, unspecified | Paralyzed | Skeletal muscle paralysis | Spastic paralysis | Unable to move limbs | Nerve paralysis | Transient paralysis | Descending symmetrical flaccid paralysis | Brachiofacial paralysis | Transient spastic paralysis | Paralyses | Plegia | Plegias | Palsies | Todd Paralysis | Paralysis, Todd | Todd's Paralysis | Paralysis, Todd's | Todds Paralysis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02392Zoledronic acid0.007157%
BADD_D02412Octreotide--
BADD_D02423Fondaparinux0.007401%
BADD_D02432Glycopyrronium0.001891%
BADD_D02436Atorvastatin0.000018%
BADD_D02464Fingolimod0.003303%
BADD_D02469Edoxaban0.000082%
BADD_D02473Sodium chloride0.000241%
BADD_D02484Istradefylline0.000367%
BADD_D02488Esketamine0.000185%
BADD_D02511Siponimod0.000241%
BADD_D02537Cabotegravir0.000282%
BADD_D02558Gadolinium cation (3+)-
BADD_D02562Lasmiditan0.000067%
BADD_D02569Magnesium0.000294%
The 9th Page    First    Pre   9    Total 9 Pages